MY8700654A - Aqueous suspension of oxendolone - Google Patents

Aqueous suspension of oxendolone

Info

Publication number
MY8700654A
MY8700654A MY654/87A MY8700654A MY8700654A MY 8700654 A MY8700654 A MY 8700654A MY 654/87 A MY654/87 A MY 654/87A MY 8700654 A MY8700654 A MY 8700654A MY 8700654 A MY8700654 A MY 8700654A
Authority
MY
Malaysia
Prior art keywords
oxendolone
aqueous suspension
suspension
aqueous
Prior art date
Application number
MY654/87A
Other languages
English (en)
Inventor
Noda Etsunosuke
Matukura Yoshiharu
Nagai Akiro
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of MY8700654A publication Critical patent/MY8700654A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MY654/87A 1981-08-18 1987-12-30 Aqueous suspension of oxendolone MY8700654A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56129517A JPS5832899A (ja) 1981-08-18 1981-08-18 オキセンドロン水性懸濁剤

Publications (1)

Publication Number Publication Date
MY8700654A true MY8700654A (en) 1987-12-31

Family

ID=15011450

Family Applications (1)

Application Number Title Priority Date Filing Date
MY654/87A MY8700654A (en) 1981-08-18 1987-12-30 Aqueous suspension of oxendolone

Country Status (13)

Country Link
US (1) US4462996A (el)
EP (1) EP0072662B1 (el)
JP (1) JPS5832899A (el)
KR (1) KR880001806B1 (el)
AR (1) AR230730A1 (el)
CA (1) CA1176983A (el)
DE (1) DE3263754D1 (el)
ES (1) ES515057A0 (el)
GR (1) GR76258B (el)
HK (1) HK23888A (el)
MY (1) MY8700654A (el)
PT (1) PT75435B (el)
SG (1) SG110187G (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
BRPI0415531B8 (pt) * 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
CA2622758A1 (en) * 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
AR067747A1 (es) * 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd Metodos para producir suspension de aripiprazol y formulacion liofilizada

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
JPS4832643A (el) * 1971-09-02 1973-05-01
JPS4966815A (el) * 1972-10-25 1974-06-28

Also Published As

Publication number Publication date
ES8403719A1 (es) 1984-04-01
JPS5832899A (ja) 1983-02-25
US4462996A (en) 1984-07-31
HK23888A (en) 1988-04-08
SG110187G (en) 1988-05-20
EP0072662A2 (en) 1983-02-23
GR76258B (el) 1984-08-04
JPS6361957B2 (el) 1988-11-30
AR230730A1 (es) 1984-06-29
ES515057A0 (es) 1984-04-01
CA1176983A (en) 1984-10-30
EP0072662A3 (en) 1983-08-24
KR880001806B1 (ko) 1988-09-19
PT75435B (pt) 1985-05-31
PT75435A (pt) 1982-09-01
KR840000901A (ko) 1984-03-26
DE3263754D1 (en) 1985-06-27
EP0072662B1 (en) 1985-05-22

Similar Documents

Publication Publication Date Title
DE3268241D1 (en) Strut type suspension
GB2128558B (en) Construction of suspension arms
JPS54155200A (en) Aqueous suspension of sodium aluminosilicate
DE3564955D1 (en) Aqueous suspensions of solid particles
PL235453A1 (en) Method of manufacture of guanidine derivatives
JPS6460688A (en) Aqueous arylfluorophosphite suspension
PL235333A1 (en) Method of manufacture of guanidine derivatives
GB2099451B (en) Aqueous coal suspension
GB2026006B (en) Aqueous suspension
DE3263754D1 (en) Aqueous suspension of oxendolone
DE3267729D1 (en) Suspension strut assembly
JPS57147977A (en) Monocross suspension structure of autobicycle
ZA823135B (en) Aqueous coal suspension
JPS57147978A (en) Monocross suspension structure of autobicycle
ZA827270B (en) Thiosulfenamide derivatives of n-phosphonomethylglycinonitriles
GB2107309B (en) Preparation of 2-amino-4-hydroxy-5-halo-substituted pyrimidine derivatives
GB2107057B (en) Suspension system
PL239273A1 (en) Method of manufacture of derivatives of guanidine
JPS57147905A (en) Suspension strut assembly
JPS57191397A (en) Dimension stabilizer of paper
GB2090842B (en) Aqueous dispersion
PL239276A1 (en) Method of obtaining guanidine derivatives
JPS57201479A (en) Assembling of suspension door
JPS57193596A (en) Dimension stabilizer of paper
JPS57191396A (en) Dimension stabilizer of paper